Henry E. Pelish - Jul 9, 2024 Form 3 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan McConarty, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jul 9, 2024
Transactions value $
$0
Form type
3
Date filed
7/11/2024, 04:45 PM
Next filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NUVL Class A Common Stock 63.5K Jul 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 5.91K $0.65 Direct F2
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 9.63K $0.87 Direct F3
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 8.09K $1.08 Direct F4
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 3.26K $6.89 Direct F5
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 18.3K $18.93 Direct F6
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 32.5K $27.85 Direct F7
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 32.2K $29.33 Direct F8
holding NUVL Stock Option (Right to Buy) Jul 9, 2024 Class A Common Stock 28.9K $72.35 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 20,200 shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following January 5, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F2 The shares underlying this option are fully vested.
F3 The shares underlying this option vest as follows: 25% of the 57,759 shares originally underlying the option vested on August 3, 2021 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F4 The shares underlying this option vest as follows: 25% of the 27,720 shares originally underlying the option vested on February 1, 2022 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F5 The shares underlying this option vest as follows: 25% of the 9,198 shares originally underlying the option vested on April 29, 2022 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F6 The shares underlying this option vest as follows: 25% of the 35,100 shares originally underlying the option vested on January 4, 2023 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F7 The 42,100 shares originally underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F8 The 39,600 shares originally underlying this option have vested or shall vest over the four years following March 1, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F9 The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Remarks:

Exhibit Index: 24.1 - Power of Attorney